Bahrain has won international acclaim for its pioneering medical initiative to treat sickle cell disease (SCD) patients.
World Health Organisation (WHO) director-general Tedros Adhanom Ghebreyesus congratulated the country over the successful treatment of Bahraini SCD sufferer Amjad Al Mahari, who has become the first patient outside the United States to be administered Casgevy, a CRISPR-based gene-editing therapy using bone marrow transplantation technology, at the Royal Medical Services-Bahrain Oncology Centre .
&uuid=(email))